Publications (original articles or review articles) published in 2023 from OUS - Dept. of Microbiology, Dudman - Clinical Virology Research Group
19 publications found
Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19
JAMA Netw Open, 6 (12), e2346502
DOI 10.1001/jamanetworkopen.2023.46502, PubMed 38147336
Neurological manifestations of COVID-19 in adults and children
Brain, 146 (4), 1648-1661
DOI 10.1093/brain/awac332, PubMed 36087305
Antibiotic Consumption in a Cohort of Hospitalized Adults with Viral Respiratory Tract Infection
Antibiotics (Basel), 12 (4)
DOI 10.3390/antibiotics12040788, PubMed 37107150
Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
Front Immunol, 14, 1210899
DOI 10.3389/fimmu.2023.1210899, PubMed 37503339
Nausea Predicts Bacteremia in Immunocompetent Patients with Pneumococcal Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort
J Clin Med, 12 (12)
DOI 10.3390/jcm12123924, PubMed 37373619
Tracing the adaptive evolution of SARS-CoV-2 during vaccine roll-out in Norway
Virus Evol, 10 (1), vead081
DOI 10.1093/ve/vead081, PubMed 38205440
A multi-country analysis of COVID-19 hospitalizations by vaccination status
Med, 4 (11), 797-812.e2
DOI 10.1016/j.medj.2023.08.005, PubMed 37738979
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry
Res Pract Thromb Haemost, 7 (5), 102142
DOI 10.1016/j.rpth.2023.102142, PubMed 37601011
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Int J Epidemiol, 52 (2), 355-376
DOI 10.1093/ije/dyad012, PubMed 36850054
Circulating markers of extracellular matrix remodelling in severe COVID-19 patients
J Intern Med, 294 (6), 784-797
DOI 10.1111/joim.13725, PubMed 37718572
Hepcidin analysis in pneumonia: Comparison of immunoassay and LC-MS/MS
Ann Clin Biochem, 60 (5), 298-305
DOI 10.1177/00045632231159529, PubMed 36759502
A fast, low-cost, robust and high-throughput method for viral nucleic acid isolation based on NAxtra magnetic nanoparticles
Sci Rep, 13 (1), 11714
DOI 10.1038/s41598-023-38743-0, PubMed 37474666
Major adverse cardiovascular events (MACE) in patients with severe COVID-19 registered in the ISARIC WHO clinical characterization protocol: A prospective, multinational, observational study
J Crit Care, 77, 154318
DOI 10.1016/j.jcrc.2023.154318, PubMed 37167775
Validation of extracorporeal membrane oxygenation mortality prediction and severity of illness scores in an international COVID-19 cohort
Artif Organs, 47 (9), 1490-1502
DOI 10.1111/aor.14542, PubMed 37032544
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity
FASEB J, 37 (11), e23220
DOI 10.1096/fj.202300077R, PubMed 37801035
Liver injury in hospitalized patients with COVID-19: An International observational cohort study
PLoS One, 18 (9), e0277859
DOI 10.1371/journal.pone.0277859, PubMed 37703268
Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
Crit Care, 27 (1), 69
DOI 10.1186/s13054-023-04356-2, PubMed 36814280
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19
Kidney Int Rep, 8 (8), 1514-30 (in press)
DOI 10.1016/j.ekir.2023.05.015, PubMed 37360820
Immunogenicity and safety of a two-dose regimen with hepatitis E virus vaccine in healthy adults in rural Bangladesh: A randomized, double-blind, controlled, phase 2/pilot trial
Vaccine, 41 (5), 1059-1066
DOI 10.1016/j.vaccine.2022.12.064, PubMed 36599736